http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-285980-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1989-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9984742e8bff1b26187abafb96ea5081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5935accf2eeab22ee7a8ba2121dc539b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5877442c97f966099662694dab5f30e0 |
| publicationDate | 1991-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-285980-A5 |
| titleOfInvention | PROCESS FOR THE PREPARATION OF THVOLEONOLACTONES OF THE THIENOPYRIDINE TYPE |
| abstract | The invention relates to processes for the preparation of thienopyridine-type mevalonolactones of the formula * in which the substituents R 1 to R 5, Y and Z have the meaning given in the description. The compounds of the formula (I) according to the invention are used as pharmaceuticals, in particular as anti-hyolipoproteinaemic and / or anti-atherosclerotic agents. Formula (I) {mevalonolactone production; pharmaceuticals; anti-hypolipoproteinaemisch; anti-atherosclerotic} |
| priorityDate | 1988-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.